Estimation of Serum Levels of AST, LDH, CKMB AND TCK Among HIV Patients on HAART, HAART Naïve and Controls
DOI:
https://doi.org/10.54987/jobimb.v10i2.757Keywords:
Serum, Enzymes, HIV, HAART, Naïve and ControlsAbstract
Human Immunodeficiency virus (HIV) infection is associated with increased of developing heart disease. Information on the cardiac status of HIV-infected Nigerians is lacking. HIV/AIDS infection is a global pandemic and poses a serious health challenge in sub-Saharan Africa, Nigeria inclusive. The cardiac disease may occur at any stage of HIV infection, but important manifestations are more frequent with advanced immunodeficiency. Moreover, it has been reported that complications from HIV infection include arrhythmias, heart failure myocardial infarction and coronary heart disease. This study aimed to estimate serum levels of AST, LDH, CKMB and TCK among HIV patients on HAART, HAART naïve and controls subjects attending Bauchi State Tertiary hospital, Nigeria. The results showed that the mean serum total Creatine kinase, CK-MB, LDH and AST were significantly higher in HIV participants not on HAART compared with HIV participants on HAART at P<0.05 respectively. Similarly, the mean serum total Creatine kinase, CK-MB, LDH and AST were significantly higher in symptomatic HIV participants not on HAART compared with HIV seronegative control subjects at P<0.05 in each case. Once again, the mean serum total Creatine kinase, CK-MB, LDH and AST were significantly higher in asymptomatic HIV participants compared with HIV seronegative control subjects at P<0.05 respectively. Increased levels of some cardiac markers were seen in HIV-infected participants. The study reveals that there is a need to monitor these parameters to prevent sudden cardiovascular complications in HIV seropositive patients. Hence, it is recommended that more investigations need to be carried out to further evaluate the levels of CK-MB (cardiac-specific) isoenzyme of CK and other cardiac biomarkers such as troponins I and T, and myoglobin, among others.
References
Oluboyo AO, Okogun GR, Duru LA, Oluboyo BO, Emenike F, Obasikene CN. Pattern Of Blood Pressure, Cd4+ T Cells Count And Some Cardiac Enzymes In Hiv Seropositive Subjects. J Biomed Invest. 2006;4(2):37-41
Rasool, ST, Tang, H, Wu J., and Li, W. Increased level of IL- 32 during human immunodeficiency virus infection suppresses HIV replication. Immun Lett. 2018;117: 161-167.
Kumar, Vinay. Robbins Basic Pathology (9th ed.). 2012;147.
Fauci, AS. The Epidemic. New England J Med. 1999;341:1046-1050.
World Health Organization. Interim WHO clinical staging of HIV/AIDS and HIV/ AIDS case definitions for surveillance (African Region) Access July 26th, 2016.World Health Organization (1999) World Health Report; making a difference. 2005;Geneva.
UNAIDS Report on the Global AIDS Epidemic. UNAIDS 10th Anniversary Special Edition, Geneva, (2006).
UNAIDS (2011).World AIDS report. Joint United Nations program on HIV/AIDS UNAIDS/ JC2216E.
UNAIDS. The Global report, UNAIDS Report on global AIDS epidemic Joints united nation program on HIV/AIDS UNAIDS/JC2417E. 2012
NACA,HIV/AIDS prevalence ranking by states, published by National Agency for the Control of Aids(NACA). 2015
FMOH. Technical Report of National HIV/Syphilis Sero-prevalence Sentinel Survey among Pregnant Women attending Ante-natal clinics in Nigeria' Abuja, Nigeria. 2018
FMOH. Technical Report of National HIV/Syphilis Sero-prevalence Sentinel Survey among Pregnant Women attending Ante-natal clinics in Nigeria' Abuja, Nigeria. 2020
SOSACA. 2013 and 2014 Health Sector HIV/IDS Data presented during state M&E meeting by Director, M&E. 1-7. 2015
CIA. Adult prevalence rate, 2012 CIA World Factbook, Adapted from www.cia.gov.retrieved on February, 2010.
Bonnet, F, Moriat, P, Chene, G. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999, HIV 2002;Med 3:195-199.
Currie, PF and Boon, NA. Immunopathogenesis of HIVrelated heart muscle disease: current perspectives. AIDS, 2003;17(1):21-28.
Crum, NF, Riffenburgh, RH, Wegner S. Comparison of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early and late HAART eras. J Acquir Immune Defic Syndr. 2006; 41:194-200.
Sani MU, Okeahialam BN, Aliyu SH, Enoch DA. Human immunodeficiency virus (HIV) related heart disease: a review. Wien Klin Wochenschr. 2005 Feb;117(3):73-81.
McDonald CL, Kaltman JR. Cardiovascular disease in adult and pediatric HIV/AIDS. J Am Coll Cardiol. 2009 Sep 22;54(13):1185-8.
Ochei, J and Kolhatkar A. Medical Laboratory Science theory and practice. Tata McGraw Hill. Sixth edition, 2000;p168.
Reitman, S, Frankel, S. Am J Clin Pathol.1957;28:56.
Ezeugwunne IP, Onyenekwe CC, Ahaneku JE, Ahaneku G, Ifeanyichukwu M, Meludu SC, Chukwuanukwu RC, Serah W, Nnaemeka OJ, Nnadozie O, Onah CE. Assessment of Some Cardiac Biomarkers in Adult HIV Seropositives in Nnewi, Nigeria. Assessment. 2014;6(7).
Lewis, W. Cardiomyopathy in AIDS: a pathophysiological perspective. Prog Cardiovasc Dis. 2000;43(2):151-170.
Malnick, S. & Goland, S. Dilated cardiomyopathy in HIV-infected patients. New Engl J Med. 1998;339 (16):1093-1099.
Miro, JM, Del Rio, A, & Mestres, CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Clin Cardiol. 2003;21:167-84.
Sudano I, Spieker LE, Noll G, Corti R, Weber R, Lüscher TF. Cardiovascular disease in HIV infection. Am Heart J. 2006;151(6):1147-55.
Carr A, Miller J, Law M, Cooper DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. Aids. 2000;14(3):F25-32.
Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, Monforte AD, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. Aids. 2003;17(8):1179-93.
Bello A, Mainasara AS, Liman HM, Umar H, Abubakar AF, Saidu K, Abdullahi AU. Pattern of Blood Pressure, Body Mass Index and Some Cardiac Enzymes in HIV Seropositive Patients in Sokoto, Nigeria. https://www.researchgate.net/publication/285236757_Pattern_of_Blood_Pressure_Body_Mass_Index_and_Some_Cardiac_Enzymes_in_HIV_Seropositive_Patients_in_Sokoto_Nigeria. Accessed 25th Dec 2022.
Orenstein, JM. Replication of HIV-1 in vivo and in vitro. Ultras Pathol. 2007;31:151-167.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Biochemistry, Microbiology and Biotechnology

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
